JP2013527760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527760A5 JP2013527760A5 JP2013508445A JP2013508445A JP2013527760A5 JP 2013527760 A5 JP2013527760 A5 JP 2013527760A5 JP 2013508445 A JP2013508445 A JP 2013508445A JP 2013508445 A JP2013508445 A JP 2013508445A JP 2013527760 A5 JP2013527760 A5 JP 2013527760A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- antigen
- lentiviral
- vsv
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10290238.4A EP2385107B1 (en) | 2010-05-03 | 2010-05-03 | Lentiviral vector based immunological compounds against malaria |
| EP10290238.4 | 2010-05-03 | ||
| PCT/EP2011/056887 WO2011138251A1 (en) | 2010-05-03 | 2011-04-29 | Lentiviral vector based immunological compounds against malaria |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015233691A Division JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527760A JP2013527760A (ja) | 2013-07-04 |
| JP2013527760A5 true JP2013527760A5 (https=) | 2013-08-15 |
| JP5937574B2 JP5937574B2 (ja) | 2016-06-22 |
Family
ID=42731903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508445A Active JP5937574B2 (ja) | 2010-05-03 | 2011-04-29 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
| JP2015233691A Pending JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015233691A Pending JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9109234B2 (https=) |
| EP (2) | EP2385107B1 (https=) |
| JP (2) | JP5937574B2 (https=) |
| KR (1) | KR20130096164A (https=) |
| CN (1) | CN103314104B (https=) |
| DK (1) | DK2385107T3 (https=) |
| WO (1) | WO2011138251A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
| CN103965320A (zh) * | 2013-01-29 | 2014-08-06 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| BR112015030211A2 (pt) | 2013-06-03 | 2017-08-22 | Theravectys | Vetores lentivirais contendo uma sequência promotora a montante da mhc de classe i, mhc de classe ii ou microglobulina beta-2 |
| EP2878674A1 (en) * | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Stable episomes based on non-integrative lentiviral vectors |
| EP3087188A1 (en) * | 2013-12-23 | 2016-11-02 | Theravectys | Lyophilized lentiviral vector particles, compositions and methods |
| US10010607B2 (en) | 2014-09-16 | 2018-07-03 | Institut Curie | Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response |
| CN106290840A (zh) * | 2015-05-13 | 2017-01-04 | 上海凯创生物技术有限公司 | 间日疟原虫乳胶法检测试剂盒 |
| CN105754962A (zh) * | 2016-01-07 | 2016-07-13 | 中南大学 | 一种单循环复制艾滋病毒样颗粒及其制备方法和应用 |
| WO2017157437A1 (en) | 2016-03-16 | 2017-09-21 | Institut Curie | Method for preparing viral particles with cyclic dinucleotide and use of said particles for treating cancer |
| EP3458086A4 (en) * | 2016-05-19 | 2020-07-29 | The Trustees Of The University Of Pennsylvania | SYNTHETIC IMMUNOGENS TO MALARIA, COMBINATIONS OF THEM AND THEIR USE TO PREVENT AND TREAT MALARIA INFECTIONS |
| CA3069780A1 (en) | 2016-08-09 | 2018-02-15 | Aarhus Universitet | Modulation of ifi16 and sting activity |
| EP3357506A1 (en) * | 2017-02-02 | 2018-08-08 | Institut Pasteur | Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host |
| EP3357504A1 (en) * | 2017-02-02 | 2018-08-08 | Institut Pasteur | Functional screening of antigenic polypeptides - use for the identification of antigens eliciting a protective immune response and for the selection of antigens with optimal protective activity |
| CN109251929A (zh) * | 2018-04-27 | 2019-01-22 | 杭州贝英福生物科技有限公司 | 一种干扰二化螟几丁质酶基因CsCht10的siRNA |
| EP3796931A1 (en) | 2018-05-23 | 2021-03-31 | Institut Pasteur | Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host |
| EP3820997A4 (en) * | 2018-07-09 | 2022-09-21 | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | Viral-vectored vaccine for malaria |
| CN109022456B (zh) * | 2018-07-24 | 2021-03-02 | 江南大学 | 一种表达卵形疟原虫ama1蛋白的病毒疫苗的制备方法 |
| GB201906283D0 (en) * | 2019-05-03 | 2019-06-19 | Moredun Res Institute | Vector |
| CN116322793A (zh) * | 2020-09-01 | 2023-06-23 | 宾夕法尼亚大学董事会 | 改进的使用科卡尔包膜的t细胞转导用慢病毒载体的生成 |
| US12304929B2 (en) * | 2021-04-12 | 2025-05-20 | Sk Bioscience Co., Ltd. | Recombinant RSV live vaccine strain and the preparing method thereof |
| EP4326769A1 (en) | 2021-04-20 | 2024-02-28 | Institut Curie | Compositions and methods for use in immunotherapy |
| EP4326321A1 (en) | 2021-04-20 | 2024-02-28 | Institut Curie | Compositions and methods for use in immunotherapy |
| CN116987157B (zh) * | 2023-09-27 | 2023-11-28 | 深圳华大生命科学研究院 | 一种弹状病毒包膜蛋白、含其的靶向慢病毒载体及其应用 |
| CN121005787B (zh) * | 2025-10-22 | 2025-12-26 | 南京鸿明生物科技有限公司 | 一种嵌合型包膜糖蛋白、其制备方法及涉及该包膜糖蛋白的包膜质粒、包装方法和试剂盒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766597A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Malaria recombinant poxviruses |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| ATE449858T1 (de) | 1999-10-11 | 2009-12-15 | Pasteur Institut | Lentivirale vektoren für die herstellung von immunotherapeutischen zusammensetzungen |
| ATE351916T1 (de) | 1999-10-12 | 2007-02-15 | Pasteur Institut | Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten |
| DK200201741A (da) | 2002-11-12 | 2003-09-16 | Statens Seruminstitut | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
| WO2004055187A1 (en) | 2002-12-17 | 2004-07-01 | Crucell Holland B.V. | Recombinant viral-based malaria vaccines |
| FR2872170B1 (fr) | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
| US8158413B2 (en) | 2005-10-17 | 2012-04-17 | Institut Pasteur | Lentiviral vector-based vaccine |
| AU2006284756B2 (en) | 2005-08-31 | 2012-06-07 | Genvec, Inc. | Adenoviral vector-based malaria vaccines |
| WO2007095201A2 (en) * | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | Pseudotyped retroviral vectors and methods of use thereof |
| ES2708856T3 (es) | 2007-08-03 | 2019-04-11 | Pasteur Institut | Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales |
| TR201802221T4 (tr) * | 2007-08-13 | 2018-03-21 | Glaxosmithkline Biologicals Sa | Aşılar. |
-
2010
- 2010-05-03 EP EP10290238.4A patent/EP2385107B1/en active Active
- 2010-05-03 DK DK10290238.4T patent/DK2385107T3/en active
-
2011
- 2011-04-29 WO PCT/EP2011/056887 patent/WO2011138251A1/en not_active Ceased
- 2011-04-29 KR KR1020127031691A patent/KR20130096164A/ko not_active Withdrawn
- 2011-04-29 EP EP11716434A patent/EP2566956A1/en not_active Withdrawn
- 2011-04-29 US US13/695,683 patent/US9109234B2/en active Active
- 2011-04-29 JP JP2013508445A patent/JP5937574B2/ja active Active
- 2011-04-29 CN CN201180027852.4A patent/CN103314104B/zh active Active
-
2015
- 2015-07-15 US US14/799,633 patent/US9822153B2/en active Active
- 2015-11-30 JP JP2015233691A patent/JP2016041076A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527760A5 (https=) | ||
| US9109234B2 (en) | Lentiviral vector based immunological compounds against malaria | |
| CN102482329B (zh) | 用辛德毕斯病毒包膜糖蛋白假型化的慢病毒载体 | |
| ES2963179T3 (es) | Vacunas contra el virus de la hepatitis b (VHB) y usos de las mismas | |
| Coutant et al. | A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria | |
| US11857611B2 (en) | Compositions and methods for generating an immune response to treat or prevent malaria | |
| MD3390430T2 (ro) | Antigenele virusului imunodeficienței umane, vectori, compoziții și metode de utilizare ale acestora | |
| CN102046785A (zh) | 基于慢病毒的免疫原性载体 | |
| Limbach et al. | Viral vectors in malaria vaccine development | |
| Gilbert et al. | Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations | |
| Raska et al. | Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses | |
| Reeder et al. | Strategic variants of CSP delivered as SynDNA vaccines demonstrate heterogeneity of immunogenicity and protection from Plasmodium infection in a murine model | |
| Schuldt et al. | Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses | |
| JPWO2007102326A1 (ja) | アデノウイルス５型／３５型ベクターとワクシニアウイルスｍｖａベクターとの併用による強力な免疫誘導 | |
| US20220296703A1 (en) | Cobmination of hepatitis b virus (hbv) vaccines and anti-pd-1 or anti-pd-l1 antibody | |
| Sun et al. | Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy | |
| JP2022537324A (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）ワクチンおよび抗ｐｄ－１抗体の組合せ | |
| Kumar et al. | mRNA-LNP expressing PfCSP and Pfs25, two leading vaccine candidates targeting infection and transmission of Plasmodium falciparum | |
| Halbroth et al. | Salman | |
| WO2014176530A1 (en) | Vaccination methods | |
| Shahin et al. | Heterologous prime-boost immunisation regimens against infectious diseases | |
| Biswas et al. | malaria sporozoite challenge in a murine model Kunitaka Yoshida1, 2, Mitsuhiro Iyori1, Andrew M. Blagborough3, Ahmed M. Salman 4, 5, Pawan Dulal4, Katarzyna A. Sala3, Daisuke S. Yamamoto 6, Shahid M. Khan5, Chris J. Janse5 | |
| BR112012027999B1 (pt) | Partícula de vetor lentiviral, combinação de compostos, uso de partículas de vetor lentiviral e uso de uma combinação de compostos | |
| EA045279B1 (ru) | Вакцины против вируса гепатита b (hbv) и их применение |